Notable Labs Overview
- Founded
- 2014
- Status
- Private
- Employees
- 9
- Latest Deal Type
- Series B2
- Latest Deal Amount
- $40M
- Investors
- 33
Notable Labs General Information
Description
Provider of drug testing services intended to assist oncologists in identifying actionable treatment options for people with blood cancers. The company's services prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor as well as involved in discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance, enabling patients to identify personalized cancer treatment options to cure their diseases.
Contact Information
Website
Formerly Known As
StemCycle
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
- 320 Hatch Drive
- Foster City, CA 94404
- United States
+1 (415) 000-0000
Notable Labs Timeline
Notable Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Early Stage VC (Series B2) | 08-Nov-2019 | $40M | 000.00 | 00000 | Completed | Generating Revenue |
| 7. Early Stage VC (Series A1) | 16-Aug-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 6. Early Stage VC | 15-Mar-2017 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 5. Early Stage VC | 16-May-2016 | 00.000 | 00.000 | Completed | Startup | |
| 4. Early Stage VC | 01-Jun-2015 | 00000 | Completed | Startup | ||
| 3. Accelerator/Incubator | 24-Mar-2015 | 00000 | 00000 | 00.000 | Completed | Startup |
| 2. Early Stage VC | 01-Mar-2015 | Completed | Startup | |||
| 1. Early Stage VC | 01-Aug-2014 | Completed | Startup |
Notable Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 | |
| Series B-1 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-6 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-5 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-4 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-2 | 1,194,403 | $0.001000 | $2.62 | $2.62 | 1x | $2.62 | 4.53% | |
| Series A-1 | 3,583,743 | $0.001000 | $2.92 | $2.92 | 1x | $2.92 | 13.58% |
Notable Labs Executive Team (12)
Notable Labs Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| James Kim | Builders VC | Board Member | 000 0000 |
| Matthew De Silva | Notable Labs | Co-Founder & Chairman | 000 0000 |
Notable Labs Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNotable Labs Investors (33)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Alumni Ventures Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| B Capital Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| d:tribe capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Industry Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| IOVC | Venture Capital | Minority | 000 0000 | 000000 0 |